Search results
Results from the WOW.Com Content Network
In 1999, Panacea Medical Technologies Pvt. Ltd. was founded in Bangalore by a senior scientist G V Subramanhyam. The company has worked with the Bhabha Atomic Research Centre (BARC) and Society for Applied Microwave Electronic Engineering and Research (SAMEER) to collaborate on the design of a tele-cobalt radiotherapy unit [6] and linear accelerator. [8]
Illustration of Implantable Cardioverter Defibrillator (ICD) An implantable cardioverter-defibrillator (ICD) or automated implantable cardioverter defibrillator (AICD) is a device implantable inside the body, able to perform defibrillation, and depending on the type, cardioversion and pacing of the heart.
Pulse oximeters specifically intended for medical use do fall under FDA purview. It’s these device manufacturers that the agency is targeting with its draft guidance. How pulse oximeters work
This article needs to be updated.The reason given is: the section related to E.U. needs further updates (esp. in sections 3.2 and 4.2.2) as the directives 93/42/EEC on medical devices and 90/385/EEC on active implantable medical devices have been fully repealed on 26 May 2021 by Regulation (EU) no. 2017/745 (MDR); furthermore, Brexit triggers updates in these sections (U.K. developed their own ...
At least 11 employees working at the FDA's Center for Devices and Radiological Health - which oversees medical device reviews - have received calls since Friday saying they could return to work on ...
Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy , radiosurgery , proton therapy , and brachytherapy .
In 2023, the Department of Defense awarded Kuleana Technology, the University of Washington, and Brooke Army Medical Center, in San Antonio, Texas, a $4 million grant to conduct animal trials.
In 2017, Codman Neurosurgery, part of Depuy Synthes, was acquired by medical device maker Integra LifeSciences for $1.045 billion. [ 9 ] On September 14, 2023, Johnson & Johnson announced its MedTech and pharmaceutical segments were uniting under the Johnson & Johnson brand name.